» Articles » PMID: 26678083

Ultra-fast, Label-free Isolation of Circulating Tumor Cells from Blood Using Spiral Microfluidics

Overview
Journal Nat Protoc
Specialties Biology
Pathology
Science
Date 2015 Dec 19
PMID 26678083
Citations 180
Authors
Affiliations
Soon will be listed here.
Abstract

Circulating tumor cells (CTCs) are rare cancer cells that are shed from primary or metastatic tumors into the peripheral blood circulation. Phenotypic and genetic characterization of these rare cells can provide important information to guide cancer staging and treatment, and thus further research into their characteristics and properties is an area of considerable interest. In this protocol, we describe detailed procedures for the production and use of a label-free spiral microfluidic device to allow size-based isolation of viable CTCs using hydrodynamic forces that are present in curvilinear microchannels. This spiral system enables us to achieve ≥ 85% recovery of spiked cells across multiple cancer cell lines and 99.99% depletion of white blood cells in whole blood. The described spiral microfluidic devices can be produced at an extremely low cost using standard microfabrication and soft lithography techniques (2-3 d), and they can be operated using two syringe pumps for lysed blood samples (7.5 ml in 12.5 min for a three-layered multiplexed chip). The fast processing time and the ability to collect CTCs from a large patient blood volume allows this technique to be used experimentally in a broad range of potential genomic and transcriptomic applications.

Citing Articles

Integrated microfluidics-based construction of anti-BTN2A2 gel droplet cell preparations for non-invasive tumor-infiltrating lymphocyte therapy.

Tian Y, Li J, Yang N, Zhao Y, Zuo J, Xiong H Mater Today Bio. 2025; 31:101545.

PMID: 40026625 PMC: 11869011. DOI: 10.1016/j.mtbio.2025.101545.


Microfluidics engineering towards personalized oncology-a review.

Mishra S, Kumarasamy M In Vitro Model. 2025; 2(3-4):69-81.

PMID: 39871996 PMC: 11756504. DOI: 10.1007/s44164-023-00054-z.


Efficient Particle Manipulation Using Contraction-Expansion Microchannels Embedded with Hook-Shaped Arrays.

Huang D, Zhao Y, Cao C, Zhao J Micromachines (Basel). 2025; 16(1).

PMID: 39858738 PMC: 11767759. DOI: 10.3390/mi16010083.


Microfluidics on lensless, semiconductor optical image sensors: challenges and opportunities for democratization of biosensing at the micro-and nano-scale.

Hu X, Abbasi R, Wachsmann-Hogiu S Nanophotonics. 2024; 12(21):3977-4008.

PMID: 39635640 PMC: 11501743. DOI: 10.1515/nanoph-2023-0301.


Lab-on-Chip Systems for Cell Sorting: Main Features and Advantages of Inertial Focusing in Spiral Microchannels.

Petruzzellis I, Martinez Vazquez R, Caragnano S, Gaudiuso C, Osellame R, Ancona A Micromachines (Basel). 2024; 15(9).

PMID: 39337795 PMC: 11434521. DOI: 10.3390/mi15091135.


References
1.
Hyun K, Kwon K, Han H, Kim S, Jung H . Microfluidic flow fractionation device for label-free isolation of circulating tumor cells (CTCs) from breast cancer patients. Biosens Bioelectron. 2012; 40(1):206-12. DOI: 10.1016/j.bios.2012.07.021. View

2.
Tan S, Lakshmi R, Chen P, Lim W, Yobas L, Lim C . Versatile label free biochip for the detection of circulating tumor cells from peripheral blood in cancer patients. Biosens Bioelectron. 2010; 26(4):1701-5. DOI: 10.1016/j.bios.2010.07.054. View

3.
Prang N, Preithner S, Brischwein K, Goster P, Woppel A, Muller J . Cellular and complement-dependent cytotoxicity of Ep-CAM-specific monoclonal antibody MT201 against breast cancer cell lines. Br J Cancer. 2005; 92(2):342-9. PMC: 2361858. DOI: 10.1038/sj.bjc.6602310. View

4.
Huang S, Wu M, Lin Y, Hsieh C, Yang C, Lin H . High-purity and label-free isolation of circulating tumor cells (CTCs) in a microfluidic platform by using optically-induced-dielectrophoretic (ODEP) force. Lab Chip. 2013; 13(7):1371-83. DOI: 10.1039/c3lc41256c. View

5.
Rak Tkaczuk K, Goloubeva O, Tait N, Feldman F, Tan M, Lum Z . The significance of circulating epithelial cells in Breast Cancer patients by a novel negative selection method. Breast Cancer Res Treat. 2007; 111(2):355-64. DOI: 10.1007/s10549-007-9771-9. View